Anidulafungin
Eraxis, Ecalta (anidulafungin) is a small molecule pharmaceutical. Anidulafungin was first approved as Eraxis on 2006-02-17. It is used to treat abdominal abscess, candidemia, mycoses, and peritonitis in the USA. It has been approved in Europe to treat candidiasis. Eraxis's patent is valid until 2021-04-12 (FDA).
| Trade Name | Ecalta |
|---|---|
| Common Name | Anidulafungin |
| Indication | abdominal abscess, candidemia, candidiasis, mycoses, peritonitis |
| Drug Class | Antifungal antibiotics (undefined group) |
